Mapping the avoid-ome: a systematic open-science approach to predictive ADMET
Abstract
Drug discovery often fails due to unpredictable ADMET issues, which account for 30% of clinical setbacks. Conventional methods lack the atomistic detail needed to navigate the "Avoid-ome"-a finite set of proteins acting as "anti-targets". OpenADMET is an open-science initiative addressing this by creating pre-competitive, mechanistic datasets. Using high-throughput structural biology, active learning, and community challenges, it builds generalizable models grounded in structural "ground truth". By directly studying the Avoid-ome, OpenADMET facilitates an era of rational, multi-parameter drug design.
Fields of Study & Subjects
Computational Drug Discovery Methods
Protein Degradation and Inhibitors
vaccines and immunoinformatics approaches
Publication details
- Journal / source
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Volume
- 17
- Issue
- 1
- Publication date
- 25 May 2026
- Language
- EN